Top insider buys and sells disclosed on Friday
Insider trading activity was disclosed for several US-listed stocks. AIM ImmunoTech's CEO bought 31,250 shares at $0.163 each. Waste Energy's CEO purchased 219,286 shares at $0.001 each. Cleveland-Cliffs' director bought 7,400 shares at $13.49 each. Saba Capital Management bought 2,600 shares of Ellsworth Growth & Income Fund. PIMCO Dynamic Income's major shareholder sold 3,800 shares. BETA Technologies' CEO sold 30,000 shares. Teradyne's director sold 400 shares.
How this was made
The 30-second read
Why it matters
Overall market impact is minimal; individual trades may influence short‑term sentiment for the specific stocks but do not drive sector or macro moves.
Market read
Insider activity provides a modest signal for each listed company but lacks broader market relevance.
What to watch
The micro‑cap purchases (AIM, WAST) could attract speculative interest despite limited fundamentals.
Background
Weekly roundup of Form 4 insider transactions for U.S. listed companies, highlighting recent buys and sells.
Ticker impact
CEO purchased 31,250 shares at $0.163, a rare insider buy in a micro‑cap near its 52‑week low.
slight upward pressure as investors note confidence from the CEO purchase
Buy amount is small relative to market cap; may attract speculative interest but limited impact.
Chairman/CEO bought 219,286 shares at $0.001, a sizable stake increase for a $0.3 B market‑cap firm.
possible slight rally as the market perceives confidence from the chairman’s purchase
Company is extremely small and illiquid; the trade size is modest in absolute dollars.
Director bought 7,400 shares at $13.49, a modest purchase in a large‑cap miner.
little to no price movement expected
Transaction is tiny relative to float and market cap.
Saba Capital Management, a 10 % owner, bought 2,600 shares at $11.58.
slight upward pressure
Purchase amount is small relative to the fund’s existing holdings.
Saba Capital Management sold 3,800 shares of the fund, a routine insider sell.
minimal downside risk
Sell size is modest; fund remains large holder.
CEO sold 30,000 shares via 10b5‑1 plan, valued at $559k.
little effect on price
10b5‑1 sales are routine and pre‑scheduled.
Director sold 400 shares for $140k under a 10b5‑1 plan.
no material price change expected
Small transaction relative to company size.
Executive Chairman and a 10 % owner sold a total of ~196,000 shares worth ~$6.6 M.
modest downward pressure as market notes large insider sell
While the dollar amount is larger, the stock is liquid and the sell is spread over multiple trades.
Market effects
None; insider activity is company‑specific and does not affect sector trends.
None; trades are isolated to individual U.S. equities.
Low; no broader market impact.
Counterpoint
Insider sells may signal concerns about near‑term performance, but could also be routine liquidity events.
Key entities
- personThomas K. Equels
CEO/President of AIM ImmunoTech
- personScott Gallagher
Chairman and CEO of Waste Energy Corp.
- personKyle Clark
President and CEO of BETA Technologies
